Exchange: NYSE·Updated 07:30 PM EDT
ADCT logo

ADCT Adc Therapeutics SA

$1.36
$0.04
(3.03%)
Today
Closed $1.36
$0.00
(0.00%)
After Hours
Reported EarningsAug 13
Mkt Cap$173.63M
Vol1.48M

About ADCT

ADC Therapeutics SA is a clinical-stage biotechnology company, which engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.
63

Bullish Sentiment

How do you feel about ADCT?

Advertisement|Remove ads.